Milestone scientific provides business update and reports financial results for the second quarter of 2024

Secured medicare price assignment for the compuflo® epidural system in multiple u.s. states gross margin for the second quarter of 2024 increased to 76.1% from 65.0% for the same period last year driven by an increase in u.s. e-commerce sales roseland, n.j., aug. 15, 2024 (globe newswire) -- milestone scientific inc. (nyse: mlss), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provides a business update and reported financial results for the second quarter ended june 30, 2024.
MLSS Ratings Summary
MLSS Quant Ranking